Life Science IP industry map

Dear Sofia,

As one of the most challenging areas of patent law, companies in the life sciences industry must ensure they successfully leverage IP protection and enforcement strategies to secure their businesses future. 

The EU is not only a transnational economic and monetary union, but has also harmonised many regulatory and legal aspects of the pharmaceutical industry. In light of this, we have put together this Life Science IP industry map which provides a high level overview of the latest European developments affecting Intellectual Property in life sciences.

Discover how industry developments affecting IP in life sciences will have an impact on European nations including: 

  • UK: The impact of Brexit on existing European patent law in the UK
  • Germany: How the uneven distribution of marine patents may be stifling research and development
  • Sweden: Discover the opportunities for Sweden to develop into leading global player in IP
  • Poland: The use of Poland as a manufacturing site hub through global shared service centers and clinical trial facilities

For more information please contact enquire@iqpc.co.uk or phone +44 (0)207 036 1300.

We look forward to hearing your thoughts.

Kind Regards,
Jessica Bayley
Legal IQ

T: +44 (0)207 036 1300
 

IQPC Ltd: 129 Wilton Road, London, SW1V 1JZ, United Kingdom.

You may be receiving this email for a number of reasons:  from our research we have identified you to have an interest in the content of this communication; you may have expressed a previous interest in the topic addressed in this communication; you have participated in an IQPC event or we have had some previous connection, correspondence or relationship.   If you抮e a resident of Canada: You are receiving this because you opted in or attended an IQPC event.

We respect your right to privacy. Read our privacy policy.

If you no longer wish to receive marketing messages including latest industry content, you can unsubscribe here.

ID:|1-E0WIRCP